cardiovascular system
• reduced fractional shortening at age 4 and 8 weeks
|
mortality/aging
• average 107-day survival (vs 40 days for homozygous Tnni3k (WT) with transgene)
|
muscle
• reduced fractional shortening at age 4 and 8 weeks
|